Results 171 to 180 of about 25,067 (232)

Diagnosed and underdiagnosed cases of COPD in the primary care setting: Differences and similarities. [PDF]

open access: yesJ Family Med Prim Care
Filippou I   +5 more
europepmc   +1 more source

Delphi Consensus on the Management of COPD Exacerbation Syndrome in Inpatient and Outpatient Settings. [PDF]

open access: yesOpen Respir Arch
de Miguel Díez J   +5 more
europepmc   +1 more source

Hypoxic bronchodilation

Journal of Applied Physiology, 1992
Recent advances in computed tomographic imaging provide a unique method to serially and directly visualize acute physiological response in the lung. To directly investigate the airway response to hypoxia, high-resolution computed tomographic scans of the lungs of eight intact anesthetized minipigs were serially repeated before, during, and after ...
R C, Wetzel   +3 more
openaire   +2 more sources

New bronchodilators

Current Opinion in Pharmacology, 2012
Bronchodilators are central in the treatment of airway diseases including chronic obstructive pulmonary disease (COPD). Bronchodilators in COPD aim to improve lung function, reduce symptoms, prevent exacerbation, and enhance quality of life. The majority of programs in development for novel bronchodilators are focused on enhancing existing targets to ...
Garbo, Mak, Nicola A, Hanania
openaire   +2 more sources

Bronchodilators

Clinics in Chest Medicine, 2014
Maria Gabriella Matera, Mario Cazzola
exaly   +2 more sources

VISAMMIN AS BRONCHODILATOR

Journal of the American Medical Association, 1952
Visammin (khellin) is a crystalline derivative of the Middle-Eastern plant Ammi visnaga lam; it was identified as a dimethoxy-methyl-furano chromone 1 and was synthesized in 1949. 2 Samaan's 3 pharmacologic studies in the early 1930's indicated that the drug relaxed isolated muscle preparations from the bronchus of the pig and dog by a direct effect on
G L, SNIDER   +3 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy